Key result
In a canine model, beta-adrenoceptor agonists caused vasodilatation and modest enhancement of nerve stimulation-evoked vasoconstriction and noradrenaline overflow.
Prejunctional beta 2-adrenoceptor-mediated facilitation of sympathetic neurotransmission occurs in vivo but is modest compared to alpha-adrenoceptor-mediated inhibition.
Answers are grounded in this paper and cite their sources.
Supports modest prejunctional beta2 facilitation in vivo; leaves open clinical relevance versus dominant alpha inhibition.
Prejunctional beta-adrenoceptor-mediated modulation of sympathetic neurotransmission was studied in desipramine-pretreated canine blood-perfused gracilis muscle. Overflow of endogenous noradrenaline (NA) to venous plasma and vasoconstriction reflect pre- and postjunctional events in this in vivo model. The nonselective beta-adrenoceptor agonist isoprenaline (15 nM in arterial plasma) and the beta 2-selective agonist rimiterol (50 nM) caused similar vasodilatation (35-40% increase in vascular conductance, p less than 0.01), enhancement of nerve stimulation-evoked vasoconstriction (+20-25%, p less than 0.01), and NA overflow (+13%, p less than 0.05). Isoprenaline, 3 nM, evoked vasodilatation but did not alter NA overflow. Blockade of beta 2-adrenoceptors by ICI 118,551 increased basal vascular tone (+9%, p less than 0.01) and reduced nerve stimulation-evoked vasoconstriction (-7%, p less than 0.05), but failed to alter NA overflow significantly (-12%, p = 0.12). ICI 118,551 blocked all responses to the beta-adrenoceptor agonists. Thus, prejunctional beta 2-adrenoceptor-mediated facilitation of sympathetic neurotransmission could be demonstrated in vivo, but the effects were modest. Previous experiments, however, have demonstrated a considerably larger influence of alpha-adrenoceptor-mediated prejunctional modulation in this model. Hence, prejunctional modulation via beta-adrenoceptors appears to be of subordinate importance when compared with the alpha-adrenoceptor-mediated inhibitory mechanism under these physiological conditions.
No takes yet. Share an insight, caveat, or question.
Kahan et al. (1987) studied this question. Isoprenaline and rimiterol was evaluated on Vasodilatation, nerve stimulation-evoked vasoconstriction, and noradrenaline overflow (p=< 0.01). In a canine model, beta-adrenoceptor agonists caused vasodilatation and modest enhancement of nerve stimulation-evoked vasoconstriction and noradrenaline overflow.
Synapse has enriched 10 related papers. Consider them for comparative context: